Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

VTVT stock hub

vTv Therapeutics Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

VTVTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

380.7M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

VTVT

In the news

Latest news · VTVT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-78.9

P25 -105.6P50 -46.5P75 -3.1

ROIC-52

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All VTVT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

179

Groups with data

Currency

USD

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001641489
Company name	vTv Therapeutics Inc.
Country	United States
Country code	US
Cusip	918385105
Employees	26
Employees Change	3%
Employees Change Percent	13.04
Enterprise value	$291.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2015-07-30
Isin	US9183852048
Last refreshed	2026-05-10
Market cap	$380.7M
Market cap category	Small-Cap
Price	$30.68
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	VTVT
Website	https://vtvtherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.08%
FCF yield	-6.63%
P/B ratio	5.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-17.9M
Net Income	$-27M
Net Income Growth Years	0%
Profit Per Employee	$-1M
ROA	-32
Roa5y	-55.13
ROCE	-39.41
ROE	-78.95
ROIC	-51.97

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-18.25%
Cagr1y	50.73%
Cagr3y	0.55%
Cagr5y	-20.86%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$89.9M
Cash	$88.9M
Current Assets	$89.9M
Current Liabilities	$6.6M
Equity	$64.4M
Interest Coverage	-5,468
Liabilities	$25.5M
Long Term Assets	$6,000
Long Term Liabilities	$18.8M
Net Cash	$88.9M
Net Cash By Market Cap	$23.36
Net Cash Growth	143.14%
Net Debt Equity	$-1.38
Tangible Book Value	$64.4M
Tangible Book Value Per Share	$5.19
WACC	5.69

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	13.54
Net Working Capital	$-5.7M
Quick ratio	13.39
Working Capital	$83.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-45.96%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-86.66%
1Y total return	50.69%
200-day SMA	28.99
3Y total return	1.65%
50-day SMA	35.93
50-day SMA vs 200-day SMA	50over200
5Y total return	-68.95%
All Time High	560
All Time High Change	-94.52%
All Time High Date	2015-07-30
All Time Low	7.38
All Time Low Change	315.72%
All Time Low Date	2024-01-26
ATR	2.41
Beta	0.26
Beta1y	-0.42
Beta2y	0.72
Ch YTD	-23.28
High	31.92
High52	44
High52 Date	2026-01-06
High52ch	-30.27%
Low	30.68
Low52	14
Low52 Date	2025-08-13
Low52ch	119.14%
Ma50ch	-14.62%
Price vs 200-day SMA	5.83%
RSI	38.72
RSI Monthly	53.94
RSI Weekly	47.83
Sharpe ratio	0.9x
Sortino ratio	1.41
Total Return	-45.96%
Tr YTD	-23.28
Tr1m	-19.79%
Tr1w	-3.17%
Tr3m	5.72%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	1
Analyst Price Target Top	$49
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$0.24
Earnings Revenue Estimate	12,000,000x
Operating Income	$-32.8M
Price target	$53
Price Target Change	$72.75
Price Target Change Top	$59.71

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,403,384%
Float Percent	19.37%
Shares Insiders	0.36%
Shares Institutions	13.9%
Shares Out	12,409,519
Shares Qo Q	54.03%
Shares Yo Y	45.96%
Short Float	4.69%
Short Ratio	2.27
Short Shares	0.91

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-29M
Average Volume	54,829.3x
Bv Per Share	5.19
Ch10y	-86.66
Ch1m	-19.79
Ch1w	-3.17
Ch1y	50.69
Ch3m	5.72
Ch3y	1.65
Ch5y	-68.95
Ch6m	17.91
Change	-1.16%
Change From Open	-1.03
Close	31.04
Days Gap	-0.13
Depreciation Amortization	16,000
Dollar Volume	688,060.4
Earnings Date	2026-05-22
Earnings Time	amc
EBIT	$-32.8M
EBITDA	$-32.8M
EPS	$-3.2
F Score	2
FCF	$-25.3M
FCF EV Yield	-8.66x
FCF Per Share	$-2.04
Financing CF	77,441,000
Fiscal Year End	December
Founded	2,015
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-10
Last Report Date	2025-12-31
Last Split Date	2023-11-21
Last Split Type	Reverse
Last10k Filing Date	2026-03-10
Ma150	32.68
Ma150ch	-6.13%
Ma20	34.33
Ma20ch	-10.63%
Net CF	52,186,000
Next Earnings Date	2026-05-22
Open	31
Optionable	No
Position In Range	0
Post Close	30.68
Postmarket Change Percent	1.99
Postmarket Price	$31.29
Price Date	2026-05-08
Ptbv Ratio	5.91
Relative Volume	0.41x
Share Based Comp	3,775,000
Tr6m	17.91%
Us State	North Carolina
Volume	22,427

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does VTVT pay a dividend?

Capital-return profile for this ticker.

Performance

VTVT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns VTVT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.9%

Float: +19.4% of shares outstanding

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

VTVT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.7

Neutral momentum band

Price vs 200-day MA

+5.8%

50/200-day relationship not available

Beta (5Y)

0.26

Less volatile than the market

Sharpe ratio

0.90

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About VTVT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current VTVT stock rating?

vTv Therapeutics Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full VTVT analysis?

The full report lives at /stocks/VTVT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for VTVT?

The latest report frames VTVT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the VTVT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.